2nd United Conference of Quality and Validation

Theme : The Novel and Contemporary Research in Quality and Validation

Webinar on Quality and Validation | July 14-15, 2021

About The Conference

On behalf of United Conferences, we are overwhelmed to welcome all the interested participants to attend “United Conference of Quality and Validation” Webinar Event on July 14-15, 2021. This conference boats of a huge variety of Keynote presentations, plenary talks, Poster presentations and Career development programs.

United Conference on Quality and Validation aims to bring together a significant number of leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Quality and Validation. It is a foremost integrative platform for researchers, educators and practitioners alike to present and explore the latest innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Quality and Validation.

Previous Keynotes - April, 2021

President & CEO at GK Pharmaceuticals CMO, Florida, United States

Chief Compliance Officer at Engrail Therapeutics | CEO at PDC Pharma Strategy, United States

Hashim Ahmed

WHO Fellow, Sr. Director-Head Of Formulation And Manufacturing, Avomeen, United States

Ravi Kalyanaraman

Director, Global Analytical Science & Technology - Pharma & Forensics Bristol Myers Squibb, United States

Timur Güvercinci
Timur Güvercinci

Director, Head of External Supply Quality Processes and Development bei Merck Gruppe Global Quality, Germany

Gloria Carmona

Head of Quality Assessment and GMP Facilities. Andalusian Network for the design and translation of Advanced Therapies (ANd&tAT). Fundación Pública Andaluza Progreso y Salud.

Stephan O. Krause

Head of Product Quality Group at AstraZeneca Biologics, USA

Elie Arslan

Manager, Technical QA and Document Control at Ajinomoto Bio-Pharma, California, United States

Dhaval Surti
Dhaval Surti

AGM, QA with Emcure Pharmaceutical Ltd, Ahmedabad, Gujarat, India

Dishant Sanghavi

Senior Manager - Global Quality and Compliance, Sun Pharma, India

Majdi Ayoub

Quality & Validation Manager at Rieckermann GmbH Jordan​

Previous Keynotes - July, 2021

Dhaval Surti

AGM, QA with Emcure Pharmaceutical Ltd, Ahmedabad, Gujarat, India

Saidi Reddy Uppunuri
Saidi Reddy Uppunuri

Associate Director Quality Assurance at Granules Pharmaceuticals, Inc. Chantilly, Virginia, United States

Hashim Ahmed

WHO Fellow, Sr. Director-Head Of Formulation And Manufacturing, Avomeen, United States

Nikki Edner
Nikki Edner, MBA

Site Quality Head, Director Of Quality Assurance at LSNE Contract Manufacturing

Kumar Ashesh
Kumar Ashesh

CEO at Paras Biopharmaceuticals Finland Oy Oulu, North Ostrobothnia, Finland

Akihiko Hanafusa

Professor, Shibaura Institute of Technology, Japan

Rohit Sompura
Rohit Sompura

DGM QA at Sterile dosage plant of Alembic Pharmaceuticals Limited

Virtual Exhibitors


ASTE Pharmaceuticals, Medical & Laboratory Supplies

TGMP Consulting

Webinar Registration Charges

  • Keynote/ Speaker Registration 199 USD
  • Speaker Registration 149 USD
  • Delegate Registration 99 USD
  • Student Delegate Registration 50 USD
  • Poster Presentation Registration 50 USD
  • Video Presentation Registration 50 USD
  • E-Banner Registration 50 USD

Who Can Attend

  • Deans, Directors, CEO of an Organization
  • Business Development Managers
  • Chief Scientific Officers
  • R&D Researchers from Biosimilar and Biologic Industries
  • PhD Scholars
  • Professors, Associate professors, Assistant Professors
  • Drug Development Discovery Companies
  • Association, Association Presidents and Professionals
  • Formulation and Pharma Manufacturing Companies
  • Business Entrepreneurs
  • Medical Software Developing Companies
  • Manufacturing Medical Devices Companies
  • Intellectual Property Attorneys
  • Noble laureates in Health Care and Medicine
  • Pharmacists
  • Bio-instruments and Bio-informatics Professionals
  • Research Institutes and members
  • Pharmacy Institutes

Why Choose Us

  • Global & Local Expertise
  • Prospective Attendees
  • Larger worldview of the profession
  • We’re passionate about what we do
  • We focus on your career growth
  • Transparency in Communication
  • Open gateway towards INNOVATION
  • Strong sense of identification
  • Quality without compromise
  • Quality without compromise
  • Highly organised and structured scientific programs

Key Takeaways

  • Professional Worldwide
  • International Recognition of Researchers
  • Knowledge into Asset
  • Cognizance of leading Cutting – Edge technologies
  • Publication of Abstracts in preeminent supported journals
  • New Accomplishments with Edu – tech ideas
  • Exposure to the upcoming business trends
  • Free access to our forthcoming International events
  • Certificate of presentation with International signatories

United Pharma Technologies Collaborations and Associations

Mayra Liz Guzman-Kaslow
President & CEO at GK Pharmaceuticals CMO
Florida, United States
Biography: Mayra Liz Guzman-Kaslow is the Chairman and General Manager of GK Pharmaceuticals Contract Manufacturing Operations "GK CMO PR", sister company of GK Regulatory Compliance Corporation in Jacksonville FL-USA.

"GK-CMO PR" is the first and only Pharmaceutical and Biotechnology company in Puerto Rico that have the technology and capacity to perform Contract Development and Manufacturing Operations for Biosimilars, Biologics, Drug Substances, and Solid Drug products at the same facilities.
Also, Mayra is President & CEO / Principal Partner of GK Regulatory Compliance Corporation USA who is responsible to support all the technical projects, operations and manages our Jacksonville, FL office, and project portfolio.

Mayra hold a Master of Science in, Thermodynamics and Materials Sciences Engineering from the University of Cincinnati, OH, and 2 Bachelor in Science, (1st) in Analytical Chemistry, and (2nd) in Chemical Engineering from the University of Puerto Rico -- Mayaguez Campus. With over 26 years of experience and in-depth knowledge of FDA, EMA, MHRA, WHOs, ANVISA, COFEPRIS, ANMAT, CFDA KFDA, TGA, INVIMA, PMDA, SFDA, KFDA, ISO9001, ISO13485, Canadian, ICH Guidance, and regulations.

Track record for consistently meeting goals and delivering a high level sustained performance, proven the ability to build strong customer/client relationships to include conducting vendor audits and contract manufacturing oversight.
Penelope Przekop
Chief Compliance Officer at Engrail Therapeutics | CEO at PDC Pharma Strategy
Biography: Penelope Przekop, MSQA, RQAP-GCP is the CEO of PDC Pharma Strategy, a consulting firm that focuses on strategic GxP regulatory and corporate compliance. She currently dedicates half of her time to serving as Chief Compliance Officer for Engrail Therapeutics, Inc. She has 30-plus years of broad and deep pharma industry experience and is known for her creative approaches to developing efficient quality management strategies that enable companies of all sizes to build upon their unique drug development history and strengths while ensuring compliance.
Penelope earned her B.S. in Biology from Louisiana State University and her M.S in Quality Systems Engineering from the Kennesaw State University. She is a frequent industry speaker and writer. She is the author of Six Sigma for Business Excellence (McGraw-Hill). Her upcoming book, 5-Star Career (Productivity Press, fall 2021), will relay how readers can apply the proven science of quality management to career development.
Gloria Carmona
Gloria Carmona
Head of Quality Assessment and GMP Facilities. Andalusian Network for the design and translation of Advanced Therapies (ANd&tAT). Fundación Pública Andaluza Progreso y Salud.
Biography: Gloria Carmona is Head of Quality Assessment and GMP facilities in the Andalusian Network for the Design and Translation of Advanced Therapies (former Andalusian Initiative for Advanced Therapies), organization in which she has been working since 2008. She coordinates a GMP network of 10 GMP facilities, part of the Andalusian Healthcare System, and have been involved in their construction and in obtaining and renewing the GMP certificate for them. Right now, 7 out of the 10 are certified to produce Advanced Therapy Medicinal Products (ATMPs). She has experience in different positions regarding Quality assurance for biotechnological products and since 2010 has also been the Qualified Person of one GMP facility, located in Seville, in which different cell therapy and tissue engineered products are authorized.
As Head of Quality Assessment she has been involved many different ATMPs clinical trials.
She has more than 15 years of expertise in training people and coordinates an international Master in Manufacturing of Advanced Therapy Medicinal Products. She has been involved in many national and international specialized congresses in the biotechnological sector and ATMPs. 
She is a Pharmacist Graduate and has a Master in Pharmaceutical Industry.  
Stephan O. Krause
Stephan O. Krause
Head of Product Quality Group at AstraZeneca Biologics, USA
Biography: Stephan Krause, PhD, is currently Quality Director and PQL Team Leader in Development Quality, AstraZeneca Biologics. He is a results-driven leader with 20 years of technical, managerial, and executive experiences for quality and technical functions within global operations. He is a frequent conference presenter and author and has won multiple industry awards for his publications and leadership in improving industry best practices. Stephan was invited by FDA several times to present an industry perspective to the agency on relevant current topics. He is a member of PDA’s Board of Directors and is co-chair of AMTP Advisory Board and a member of the Advisory Board for Biopharmaceuticals and Regulatory Affairs/Quality.
Hashim Ahmed
Hashim Ahmed
Head of Formulation and Manufacturing at Avomeen. Wake Forest, North Carolina, United States
Biography: A pharmaceutical product development executive leader with wide experience in CMC/MS&T-product development-R&D expertise with in-depth diversified global technical and management experience. Expert in formulation/process/product development supply management; and quality assurance of pharmaceutical/consumer products. Over 26 years of experience in the United States in major, medium-to-small companies (Roche/Stiefel-GSK/Dr. Reddy's). Consumer Product Development and regulatory expert in a diverse portfolio of APIs and a wide range of dosage forms, with NDA/505b2/generic-ANDA experience.
In-depth experience in small and large molecules (proteins/peptides); orals (tablets, capsules [hard-soft gel]); controlled-modified release formulations; as well as/parenterals dosages. Expert in oral Liquids Emulsions-Suspensions, Lipids, Powders, Topicals, Transdermals, Ocular delivery, Intranasal, Aerosols. SKILLS: Proven Product Development/CMC/Regulatory Leader (26 years in the USA at different pharmaceutical technical and management capacities); currently managing general director at QLife the lead pharma company in Qatar.

Submit Manuscript

Manuscript Details

Author Details